PT2488633E - Método in vitro para obtenção de fibroblastos intrahepáticos infectados com o vírus da hepatite - Google Patents

Método in vitro para obtenção de fibroblastos intrahepáticos infectados com o vírus da hepatite Download PDF

Info

Publication number
PT2488633E
PT2488633E PT107742801T PT10774280T PT2488633E PT 2488633 E PT2488633 E PT 2488633E PT 107742801 T PT107742801 T PT 107742801T PT 10774280 T PT10774280 T PT 10774280T PT 2488633 E PT2488633 E PT 2488633E
Authority
PT
Portugal
Prior art keywords
intrahepatic
hepatitis
virus
obtaining
vitro method
Prior art date
Application number
PT107742801T
Other languages
English (en)
Inventor
Yvon Calmus
Filomena Conti
Original Assignee
Univ Paris Descartes
Assist Publ Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Descartes, Assist Publ Hopitaux De Paris filed Critical Univ Paris Descartes
Publication of PT2488633E publication Critical patent/PT2488633E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT107742801T 2009-10-16 2010-10-15 Método in vitro para obtenção de fibroblastos intrahepáticos infectados com o vírus da hepatite PT2488633E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0904962A FR2951458B1 (fr) 2009-10-16 2009-10-16 Methode de production de fibroblastes intrahepatiques infectes par le virus de l'hepatite c

Publications (1)

Publication Number Publication Date
PT2488633E true PT2488633E (pt) 2014-01-13

Family

ID=42133719

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107742801T PT2488633E (pt) 2009-10-16 2010-10-15 Método in vitro para obtenção de fibroblastos intrahepáticos infectados com o vírus da hepatite

Country Status (6)

Country Link
US (1) US20130101986A1 (pt)
EP (1) EP2488633B1 (pt)
ES (1) ES2437922T3 (pt)
FR (1) FR2951458B1 (pt)
PT (1) PT2488633E (pt)
WO (1) WO2011045772A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2010294C2 (en) * 2013-02-13 2014-08-14 Boudewijn John Sambeek Connection device, assembly thereof and assembly method therefor.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017391B2 (en) * 2006-03-16 2011-09-13 Univesity of Florida Research Foundation, Inc. Human liver cancer cell line

Also Published As

Publication number Publication date
EP2488633A1 (fr) 2012-08-22
EP2488633B1 (fr) 2013-10-09
WO2011045772A1 (fr) 2011-04-21
FR2951458B1 (fr) 2011-12-16
ES2437922T3 (es) 2014-01-15
US20130101986A1 (en) 2013-04-25
FR2951458A1 (fr) 2011-04-22

Similar Documents

Publication Publication Date Title
HUS1500019I1 (hu) Hepatitisz C vírus inhibitorok
IL219516A0 (en) Hepatitis c virus inhibitors
HK1163067A1 (en) Hepatitis c virus inhibitors
IL219517A0 (en) Hepatitis c virus inhibitors
ZA201106795B (en) Hepatitis c virus inhibitors
ZA201106669B (en) Hepatitis c virus inhibitors
IL215095A0 (en) Hepatitis c virus inhibitors
ZA201106629B (en) Hepatitis c virus inhibitors
EP2512480A4 (en) HEPATITIS C-VIRUS HEMMER
EP2475256A4 (en) HEPATITIS C-VIRUS HEMMER
EP2501723A4 (en) HEPATITIS B-VIRUS-SPECIFIC ANTIBODIES AND APPLICATIONS THEREOF
HK1143812A1 (en) Hepatitis c virus inhibitors
ZA201105349B (en) Methods for amplifying hepatitis c virus nucleic acids
EP2528436A4 (en) INHIBITORS OF HEPATITIS C VIRUS
EP2575819A4 (en) INHIBITORS OF HEPATITIS C VIRUS
EP2621931A4 (en) TETRACYCLIC INDOLATE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION
EP2331125A4 (en) IMMUNOTHERAPY FOR CHRONIC HEPATITIS C-VIRUS INFECTIONS
IL224298A (en) Hepatitis virus inhibitors c
EP2603080A4 (en) HEPATITIS C-VIRUS HEMMER
EP2484378A4 (en) VACCINE COMPOSITION AGAINST HEPATITIS C VIRUS
HK1165694A1 (zh) 密碼子優化的乙型肝炎病毒核心抗原
PT2488633E (pt) Método in vitro para obtenção de fibroblastos intrahepáticos infectados com o vírus da hepatite
EP2615104A4 (en) LIPOSOMAL VACCINE AGAINST HEPATITIS C VIRUS
ZA201205639B (en) Compositions and methods for treating hepatitis b virus infection
EP2626426A4 (en) HEPATITIS C VIRUS-GEN